• LAST PRICE
    24.1200
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    24.2900/ 6
  • Ask / Lots
    24.3200/ 17
  • Open / Previous Close
    --- / 24.1200
  • Day Range
    ---
  • 52 Week Range
    Low 23.8000
    High 36.1200
  • Volume
    924
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 23.83
TimeVolumeGMAB
09:32 ET945924
09:34 ET41123.995
09:36 ET419223.9482
09:38 ET480223.94
09:39 ET140023.94
09:41 ET134823.94
09:43 ET181223.97
09:45 ET317023.97
09:48 ET339424.005
09:50 ET517224.055
09:54 ET157224.02
09:56 ET120024.04
09:57 ET20024.05
09:59 ET10024.04
10:01 ET150024.08
10:03 ET153124.05
10:06 ET93924.01
10:08 ET210024.01
10:10 ET274224.04
10:12 ET465124.04
10:14 ET10024.07
10:15 ET102124.08
10:17 ET10024.1
10:21 ET10024.06
10:24 ET94124.05
10:26 ET209324.03
10:28 ET10024.03
10:30 ET150024.02
10:32 ET109824
10:33 ET261723.99
10:35 ET279623.9801
10:37 ET436524.01
10:39 ET10024.015
10:42 ET267124.01
10:44 ET40023.97
10:46 ET1362423.972
10:48 ET149523.97
10:50 ET312823.95
10:51 ET100023.96
10:53 ET171524
10:55 ET100023.98
10:57 ET330023.92
11:00 ET632123.89
11:02 ET798823.92
11:04 ET95223.93
11:06 ET407823.94
11:08 ET260223.93
11:09 ET46823.93
11:11 ET248823.94
11:13 ET111023.93
11:15 ET20023.93
11:18 ET30023.93
11:20 ET3911423.8658
11:22 ET138823.9
11:24 ET1157923.9
11:26 ET60423.92
11:27 ET130023.9
11:29 ET341123.96
11:31 ET93823.97
11:38 ET45023.97
11:40 ET414323.955
11:42 ET265924.01
11:44 ET462023.99
11:45 ET48323.9999
11:47 ET188524.0084
11:49 ET101624.01
11:51 ET85524
11:54 ET93924.01
11:56 ET20024.03
11:58 ET10024.04
12:00 ET80024.06
12:03 ET108024.05
12:05 ET397424.06
12:07 ET70024.04
12:09 ET97724.033512
12:12 ET34524.0458
12:14 ET42224.04
12:16 ET32024.02
12:18 ET30024.01
12:20 ET50024.03
12:21 ET21824.0341
12:23 ET416624.02
12:25 ET150024.025
12:30 ET72024.0374
12:32 ET23824.03
12:34 ET40024.03
12:36 ET160024.05
12:38 ET50024.05
12:39 ET55624.045
12:41 ET372124.035
12:43 ET10024.035
12:45 ET70024.04
12:48 ET90024.04
12:52 ET100624.01
12:54 ET10024.01
12:56 ET279624.03
12:57 ET62524
12:59 ET120524.005
01:01 ET20024.005
01:03 ET140024.01
01:08 ET20024.01
01:10 ET38423.9903
01:14 ET160023.99
01:15 ET10024
01:17 ET50023.985
01:19 ET142624
01:21 ET129823.99
01:24 ET125923.985
01:26 ET20023.98
01:28 ET1222523.96
01:30 ET10023.97
01:32 ET149423.9827
01:33 ET50024
01:35 ET51023.995
01:37 ET60023.99
01:39 ET42723.98
01:42 ET10423.98
01:44 ET22823.985
01:48 ET30023.99
01:50 ET257924
01:51 ET100024
01:53 ET50023.99
01:57 ET12623.996
02:00 ET15223.995
02:02 ET40024.005
02:04 ET263423.97
02:06 ET18423.9635
02:08 ET48423.98
02:09 ET91023.995
02:13 ET226723.99
02:15 ET124224.0193
02:18 ET25024.02
02:20 ET20024.02
02:22 ET10924.023695
02:24 ET27924.025
02:26 ET10924.02
02:27 ET20024.02
02:31 ET283024.03
02:33 ET20024.025
02:36 ET150024.0229
02:38 ET62024.03
02:40 ET79124.025
02:42 ET50024.03
02:44 ET84624.03
02:45 ET36624.035
02:47 ET32524.0399
02:49 ET67124.025
02:51 ET10524.0212
02:54 ET99024.02
02:56 ET10024.03
02:58 ET40024.03
03:02 ET413624.035
03:03 ET89924.05
03:05 ET77624.055
03:07 ET114924.05
03:09 ET516024.04
03:12 ET249124.04
03:16 ET60024.04
03:18 ET218524.03
03:20 ET152824.025
03:21 ET256924.035
03:25 ET91224.04
03:27 ET76024.03
03:30 ET110324.025
03:32 ET10024.025
03:34 ET203524.0138
03:36 ET252524.02
03:38 ET21424.025
03:41 ET171024.04
03:43 ET265024.055
03:45 ET243524.07
03:48 ET1293324.075
03:50 ET275624.0703
03:52 ET834024.075
03:54 ET450524.075
03:56 ET998324.085
03:57 ET486224.105
03:59 ET7722224.12
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesGMAB
Genmab A/S
15.8B
19.2x
+22.71%
United StatesCPRX
Catalyst Pharmaceuticals Inc
2.4B
37.4x
---
United StatesVCYT
Veracyte Inc
2.6B
-45.0x
---
United StatesGLPG
Galapagos NV
1.9B
55.1x
---
United StatesBEAM
Beam Therapeutics Inc
2.1B
-14.2x
---
United StatesMRVI
Maravai LifeSciences Holdings Inc
2.1B
-8.4x
---
As of 2024-09-27

Company Information

Genmab A/S is a Denmark-based international biotechnology company. It specializes in the creation and development of antibody therapeutics for the treatment of cancer. The Company is the creator of the approved antibodies: DARZALEX (daratumumab) for the treatment of certain multiple myeloma indications, Kesimpta for the treatment of adults with relapsing forms of multiple sclerosis, TEPEZZA (teprotumumab) for the treatment of thyroid eye disease and FASPRO, for the treatment of adult patients with certain multiple myeloma indications. The first approved Genmab created therapy Arzerra, approved for the treatment of certain chronic lymphocytic leukemia indications, is available in Japan and is also available in other territories via compassionate use or oncology access programs. Genmab develops a broad clinical and pre-clinical product pipeline, and owns four antibody technologies, DuoBody bispecific platform, HexaBody platform, DuoHexaBody platform & HexElect platform.

Contact Information

Headquarters
Carl Jacobsens Vej 30VALBY, Denmark 2500
Phone
---
Fax
---

Executives

Independent Chairman of the Board
Deirdre Connelly
President, Chief Executive Officer
Jan Van De Winkel
Independent Deputy Chairman of the Board
Pernille Erenbjerg
Chief Financial Officer, Executive Vice President
Anthony Pagano
Executive Vice President, Chief People Officer
Christopher Cozic

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$15.8B
Revenue (TTM)
$2.8B
Shares Outstanding
661.8M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.99
EPS
$1.26
Book Value
$7.25
P/E Ratio
19.2x
Price/Sales (TTM)
5.6
Price/Cash Flow (TTM)
---
Operating Margin
30.73%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.